Suchergebnisse - "Bajaj, Jasmohan S"

PubPharm (10)

1

The Use of Rifaximin in Patients With Cirrhosis

enthalten in: Hepatology (Baltimore, Md.) | 2021

von Caraceni, P. | Vargas, V. | Solà, E. | +44

2

The Evolving Challenge of Infections in Cirrhosis

enthalten in: The New England journal of medicine | 2021

von Bajaj, J. | Kamath, P. | Reddy, K.

CommentIn: N Engl J Med. 2021 Sep 16;385(12):1150-1151. - PMID 34525295

3

Microbiome : Emerging Concepts in Patients with Chronic Liver Disease

enthalten in: Clinics in liver disease | 2020

von Reuter, B. | Bajaj, J.

4

Microbiota changes and intestinal microbiota transplantation in liver diseases and cirrhosis

enthalten in: Journal of hepatology | 2020

von Bajaj, J. | Khoruts, A.

CommentIn: J Hepatol. 2020 Jun;72(6):1212-1213. - PMID 32197801

5

Alcohol, liver disease and the gut microbiota

enthalten in: Nature reviews. Gastroenterology & hepatology | 2019

von Bajaj, J.

6

Current Management of Hepatic Encephalopathy

enthalten in: The American journal of gastroenterology | 2018

von Acharya, C. | Bajaj, J.

7

New concepts on intestinal microbiota and the role of the non-absorbable antibiotics with special reference to rifaximin in digestive diseases

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2018

von Bajaj, J. | Barbara, G. | DuPont, H. | +3

8

The Human Gut Microbiome in Liver Diseases

enthalten in: Seminars in liver disease | 2017

von Davis, B. | Bajaj, J.

9

Antibiotics for the treatment of hepatic encephalopathy

enthalten in: Metabolic brain disease | 2013

von Patidar, K. | Bajaj, J.

10

Bacterial infections in end-stage liver disease : current challenges and future directions

enthalten in: Gut | 2012

von Bajaj, J. | O'Leary, J. | Wong, F. | +2

1
[1]